EGFR and breast carcinoma: Recently, Luo et al. reported a novel mechanism underlying TMEM16A-mediated breast cancer metastasis; increased TMEM16A channel activities activate EGFR/STAT3/ROCK1 signaling, and ROCK1 activation by RhoA increased TMEM16A channel activities via moesin phosphorylation at T558.